Table of Contents Author Guidelines Submit a Manuscript
Journal of Ophthalmology
Volume 2014, Article ID 157803, 8 pages
http://dx.doi.org/10.1155/2014/157803
Review Article

Gender Differences in Vogt-Koyanagi-Harada Disease and Sympathetic Ophthalmia

1Immunopathology Section, Laboratory of Immunology, National Eye Institute, National Institutes of Health, 10 Center Drive, 10/10N103, Bethesda, MD 20892-1857, USA
2Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 510060, China

Received 30 September 2013; Revised 13 January 2014; Accepted 31 January 2014; Published 5 March 2014

Academic Editor: Janet L. Davis

Copyright © 2014 Yujuan Wang and Chi-Chao Chan. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. A. Rao and A. R. Irvine Jr., “Mechanisms of inflammatory response in sympathetic ophthalmia and VKH syndrome,” Eye, vol. 11, no. 2, pp. 213–216, 1997. View at Google Scholar · View at Scopus
  2. C. C. Chan, S. M. Whitcup, and R. B. Nussenblatt, “Sympathetic ophthalmia and Vogt-Koyanagi-Harada syndrome,” in Duane's Clinical Ophthalmology, W. Tasman and E. A. Jaeger, Eds., Lippincott, Williams and Wilkins Publishers, Philadelphia, Pa, USA, 2010. View at Google Scholar
  3. R. B. Nussenblatt, “Uveitic conditions not caused by active infection,” in Uveitis: Fundamentals and Clinical Practice, R. B. Nussenblatt and S. M. Whitcup, Eds., pp. 289–318, Mosby, Philadelphia, Pa, USA, 4th edition, 2010. View at Google Scholar
  4. R. Voskuhl, “Sex differences in autoimmune diseases,” Biology of Sex Differences, vol. 2, no. 1, 2011. View at Google Scholar
  5. N. Gleicher and D. H. Barad, “Gender as risk factor for autoimmune diseases,” Journal of Autoimmunity, vol. 28, no. 1, pp. 1–6, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. D. L. Jacobson, S. J. Gange, N. R. Rose, and N. M. H. Graham, “Epidemiology and estimated population burden of selected autoimmune diseases in the United States,” Clinical Immunology and Immunopathology, vol. 84, no. 3, pp. 223–243, 1997. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Lertsumitkul, S. M. Whitcup, R. B. Nussenblatt, and C.-C. Chan, “Subretinal fibrosis and choroidal neovascularization in Vogt-Koyanagi-Harada syndrome,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 237, no. 12, pp. 1039–1045, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Al-Halafi, H. A. Dhibi, I. H. Hamade, C. T. Bou Chacra, and K. F. Tabbara, “The association of systemic disorders with Vogt-Koyanagi-Harada and sympathetic ophthalmia,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 249, no. 8, pp. 1229–1233, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Aláez, H. Flores-A, L. E. Concha del Río et al., “Major histocompatibility complex and strong human leukocyte antigen-DRB1 and gender association with Vogt-Koyanagi-Harada syndrome in Mexican Mestizos,” Human Immunology, vol. 72, no. 12, pp. 1198–1203, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. D. A. Snyder and H. H. Tessler, “Vogt-Koyanagi-Harada syndrome,” The American Journal of Ophthalmology, vol. 90, no. 1, pp. 69–75, 1980. View at Google Scholar · View at Scopus
  11. F. Chen, S. Hou, Z. Jiang et al., “CD40 gene polymorphisms confer risk of Behçet's disease but not of Vogt-Koyanagi-Harada syndrome in a Han Chinese population,” Rheumatology, vol. 51, no. 1, Article ID ker345, pp. 47–51, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Ohno, D. H. Char, S. J. Kimura, and G. R. O'Connor, “Vogt-Koyanagi-Harada syndrome,” The American Journal of Ophthalmology, vol. 83, no. 5, pp. 735–740, 1977. View at Google Scholar · View at Scopus
  13. R. S. Moorthy, H. Inomata, and N. A. Rao, “Vogt-Koyanagi-Harada syndrome,” Survey of Ophthalmology, vol. 39, no. 4, pp. 265–292, 1995. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Inomata and M. Kato, “Vogt-Koyanagi-Harada disease,” in Handbook of Clinical Neurology, P. J. Vinken, G. W. Bruyn, and H. L. Klawans, Eds., pp. 611–626, Elsevier, Amsterdam, The Netherlands, 12th edition, 1989. View at Google Scholar
  15. S. Duke-Elder and E. S. Perkins, “Sympathetic ophthalmitis,” in Diseases of the Uveal Tract, S. Duke-Elder, Ed., pp. 558–593, Mosby, St. Louis, Mo, USA, 9th edition, 1966. View at Google Scholar
  16. M. A. Zaharia, J. Lamarche, and M. Laurin, “Sympathetic uveitis 66 years after injury,” Canadian Journal of Ophthalmology, vol. 19, no. 5, pp. 240–243, 1984. View at Google Scholar · View at Scopus
  17. G. E. Marak Jr., “Recent advances in sympathetic ophthalmia,” Survey of Ophthalmology, vol. 24, no. 3, pp. 141–156, 1979. View at Google Scholar · View at Scopus
  18. J. R. Lubin, D. M. Albert, and M. Weinstein, “Sixty-five years of sympathetic ophthalmia: a clinicopathological review of 105 cases (1913–1978),” Ophthalmology, vol. 87, no. 2, pp. 109–121, 1980. View at Google Scholar · View at Scopus
  19. K. A. McClellan, F. A. Billson, and M. Filipic, “Delayed onset sympathetic ophthalmia,” Medical Journal of Australia, vol. 147, no. 9, pp. 451–454, 1987. View at Google Scholar · View at Scopus
  20. H. Goto and N. A. Rao, “Sympathetic ophthalmia and Vogt-Koyanagi-Harada syndrome,” International Ophthalmology Clinics, vol. 30, no. 4, pp. 279–285, 1990. View at Google Scholar · View at Scopus
  21. V. Gupta, A. Gupta, and M. R. Dogra, “Posterior sympathetic ophthalmia: a single centre long-term study of 40 patients from North India,” Eye, vol. 22, no. 12, pp. 1459–1464, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. A. M. Abu El-Asrar, H. Al Kuraya, and A. Al-Ghamdi, “Sympathetic ophthalmia after successful retinal reattachment surgery with vitrectomy,” European Journal of Ophthalmology, vol. 16, no. 6, pp. 891–894, 2006. View at Google Scholar · View at Scopus
  23. A. M. Abu El-Asrar and S. A. Al-Obeidan, “Sympathetic ophthalmia after complicated cataract surgery and intraocular lens implantation,” European Journal of Ophthalmology, vol. 11, no. 2, pp. 193–196, 2001. View at Google Scholar · View at Scopus
  24. X. K. Chu and C. C. Chan, “Sympathetic ophthalmia: to the twenty-first century and beyond,” Journal of Ophthalmic Inflammation and Infection, vol. 3, no. 1, article 49, 2013. View at Google Scholar
  25. M. Reynard, R. S. Riffenburgh, and D. S. Minckler, “Morphological variation of Dalen-Fuchs nodules in sympathetic ophthalmia,” British Journal of Ophthalmology, vol. 69, no. 3, pp. 197–201, 1985. View at Google Scholar · View at Scopus
  26. C. T. Chuang, P. S. Huang, S. C. Chen, and S. J. Sheu, “Reversible alopecia in Vogt-Koyanagi-Harada disease and sympathetic ophthalmia,” Journal of Ophthalmic Inflammation and Infection, vol. 3, no. 1, article 41, 2013. View at Google Scholar
  27. D. J. Kilmartin, A. D. Dick, and J. V. Forrester, “Sympathetic ophthalmia risk following vitrectomy: should we counsel patients?” British Journal of Ophthalmology, vol. 84, no. 5, pp. 448–449, 2000. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Beniz, D. J. Forster, J. S. Lean, R. E. Smith, and N. A. Rao, “Variations in clinical features of the Vogt-Koyanagi-Harada syndrome,” Retina, vol. 11, no. 3, pp. 275–280, 1991. View at Publisher · View at Google Scholar · View at Scopus
  29. P. E. Rubsamen and J. D. M. Gass, “Vogt-Koyanagi-Harada syndrome: clinical course, therapy, and long-term visual outcome,” Archives of Ophthalmology, vol. 109, no. 5, pp. 682–687, 1991. View at Google Scholar · View at Scopus
  30. H. S. Al-Mezaine, D. Kangave, and A. M. Abu El-Asrar, “Patterns of uveitis in patients admitted to a university hospital in Riyadh, Saudi Arabia,” Ocular Immunology and Inflammation, vol. 18, no. 6, pp. 424–431, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. A. S. Al-Kharashi, H. Aldibhi, H. Al-Fraykh, D. Kangave, and A. M. Abu El-Asrar, “Prognostic factors in Vogt-Koyanagi-Harada disease,” International Ophthalmology, vol. 27, no. 2-3, pp. 201–210, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Khairallah, S. B. Yahia, A. Ladjimi et al., “Pattern of uveitis in a referral centre in Tunisia, North Africa,” Eye, vol. 21, no. 1, pp. 33–39, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. T. Wakabayashi, Y. Morimura, Y. Miyamoto, and A. A. Okada, “Changing patterns of intraocular inflammatory disease in Japan,” Ocular Immunology and Inflammation, vol. 11, no. 4, pp. 277–286, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. S. I. Murthy, M. R. Moreker, V. S. Sangwan, R. C. Khanna, and S. Tejwani, “The spectrum of Vogt-Koyanagi-Harada disease in South India,” International Ophthalmology, vol. 27, no. 2-3, pp. 131–136, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. R. Belfort Jr., M. Nishi, S. Hayashi, M. T. Abreu, A. M. N. Petrilli, and R. C. A. Plut, “Vogt-Koyanagi-Harada's disease in Brazil,” Japanese Journal of Ophthalmology, vol. 32, no. 3, pp. 344–347, 1988. View at Google Scholar · View at Scopus
  36. I. Tugal-Tutkun, Y. Ozyazgan, Y. A. Akova et al., “The spectrum of Vogt-Koyanagi-Harada disease in Turkey: VKH in Turkey,” International Ophthalmology, vol. 27, no. 2-3, pp. 117–123, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Sukavatcharin, J. H. Tsai, and N. A. Rao, “Vogt-Koyanagi-Harada disease in hispanic patients,” International Ophthalmology, vol. 27, no. 2-3, pp. 143–148, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. Y. Sasamoto, S. Ohno, and H. Matsuda, “Studies on corticosteroid therapy in Vogt-Koyanagi-Harada disease,” Ophthalmologica, vol. 201, no. 3, pp. 162–167, 1990. View at Google Scholar · View at Scopus
  39. S. Hou, P. Yang, L. Xie, L. Du, H. Zhou, and Z. Jiang, “Monocyte chemoattractant protein (MCP)-1-2518 A/G SNP in Chinese Han patients with VKH syndrome,” Molecular Vision, vol. 15, pp. 1537–1541, 2009. View at Google Scholar · View at Scopus
  40. S. Hou, P. Yang, L. Du et al., “Small ubiquitin-like modifier 4 (SUMO4) polymorphisms and Vogt-Koyanagi-Harada (VKH) syndrome in the Chinese Han population,” Molecular Vision, vol. 14, pp. 2597–2603, 2008. View at Google Scholar · View at Scopus
  41. Q. Meng, X. Liu, P. Yang et al., “PDCD1 genes may protect against extraocular manifestations in Chinese Han patients with Vogt-Koyanagi-Harada syndrome,” Molecular Vision, vol. 15, pp. 386–392, 2009. View at Google Scholar · View at Scopus
  42. Z. Jiang, P. Yang, S. Hou, F. Li, and H. Zhou, “Polymorphisms of IL23R and Vogt-Koyanagi-Harada syndrome in a Chinese Han population,” Human Immunology, vol. 71, no. 4, pp. 414–417, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. K. Hu, P. Yang, Z. Jiang, S. Hou, L. Du, and F. Li, “STAT4 polymorphism in a Chinese Han population with Vogt-Koyanagi-Harada syndrome and Behçet's disease,” Human Immunology, vol. 71, no. 7, pp. 723–726, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. Q. Shu, P. Yang, S. Hou et al., “Interleukin-17 gene polymorphism is associated with Vogt-Koyanagi-Harada syndrome but not with Behçet's disease in a Chinese Han population,” Human Immunology, vol. 71, no. 10, pp. 988–991, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. Y. Chen, P. Yang, F. Li et al., “Association analysis of TGFBR3 gene with Vogt-Koyanagi-Harada disease and Behcet's disease in the Chinese Han population,” Current Eye Research, vol. 37, no. 4, pp. 312–317, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. S.-P. Chee, A. Jap, and K. Bacsal, “Spectrum of Vogt-Koyanagi-Harada disease in Singapore,” International Ophthalmology, vol. 27, no. 2-3, pp. 137–142, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. S.-P. Chee, A. Jap, and K. Bacsal, “Prognostic factors of Vogt-Koyanagi-Harada disease in Singapore,” The American Journal of Ophthalmology, vol. 147, no. 1, pp. 154.e1–161.e1, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. N. Tesavibul and W. Sansanayuth, “Vogt-Koyanagi-Harada disease in thai patients,” Journal of the Medical Association of Thailand, vol. 88, no. 9, pp. S26–S30, 2005. View at Google Scholar · View at Scopus
  49. M. Alam, M. Iqbal, B. S. Khan, and I. Hussain, “Vogt Koyanagi Harada disease: treatment and visual prognosis,” Journal of the College of Physicians and Surgeons Pakistan, vol. 23, no. 10, pp. 740–742, 2013. View at Google Scholar
  50. Z. Friedman, M. Granat, and E. Neumann, “The syndrome of Vogt-Koyanagi-Harada and pregnancy,” Metabolic Ophthalmology, vol. 4, no. 3, pp. 147–149, 1980. View at Google Scholar · View at Scopus
  51. L. P. Steahly, “Vogt-Koyanagi-Harada syndrome and pregnancy,” Annals of ophthalmology, vol. 22, no. 2, pp. 59–62, 1990. View at Google Scholar · View at Scopus
  52. M. Nohara, K. Norose, and K. Segawa, “Vogt-Koyanagi-Harada disease during pregnancy,” British Journal of Ophthalmology, vol. 79, no. 1, pp. 94–95, 1995. View at Google Scholar · View at Scopus
  53. N. P. Chiam, A. J. Hall, R. J. Stawell, L. Busija, and L. L. Lim, “The course of uveitis in pregnancy and postpartum,” British Journal of Ophthalmology, vol. 97, no. 10, pp. 1284–1288, 2013. View at Google Scholar
  54. P. K. Rabiah and A. T. Vitale, “Noninfectious uveitis and pregnancy,” The American Journal of Ophthalmology, vol. 136, no. 1, pp. 91–98, 2003. View at Publisher · View at Google Scholar · View at Scopus
  55. L. I. Kump, R. A. Cervantes-Castañeda, S. N. Androudi, C. S. Foster, and W. G. Christen, “Patterns of exacerbations of chronic non-infectious uveitis in pregnancy and puerperium,” Ocular Immunology and Inflammation, vol. 14, no. 2, pp. 99–104, 2006. View at Publisher · View at Google Scholar · View at Scopus
  56. A. Elias, M. Gopalakrishnan, S. Bhat, and G. Anantharaman, “Vogt-Koyanagi-Harada disease clinical course, therapy, complications and prognostic factors,” World Journal of Retina and Vitreous, vol. 2, no. 2, pp. 46–52, 2012. View at Google Scholar
  57. D. Fairweather, S. Frisancho-Kiss, and N. R. Rose, “Sex differences in autoimmune disease from a pathological perspective,” The American Journal of Pathology, vol. 173, no. 3, pp. 600–609, 2008. View at Publisher · View at Google Scholar · View at Scopus
  58. K. S. Tan, “Premenstrual asthma: epidemiology, pathogenesis and treatment,” Drugs, vol. 61, no. 14, pp. 2079–2086, 2001. View at Google Scholar · View at Scopus
  59. S. R. Rudge, I. C. Kowanko, and P. L. Drury, “Menstrual cyclicity of finger joint size and grip strength in patients with rheumatoid arthritis,” Annals of the Rheumatic Diseases, vol. 42, no. 4, pp. 425–430, 1983. View at Google Scholar · View at Scopus
  60. H. P. Stevens, L. S. Ostlere, C. M. Black, H. S. Jacobs, and M. H. A. Rustin, “Cyclical psoriatic arthritis responding to anti-oestrogen therapy,” British Journal of Dermatology, vol. 129, no. 4, pp. 458–460, 1993. View at Publisher · View at Google Scholar · View at Scopus
  61. C. Sanghvi, K. Aziz, and N. P. Jones, “Uveitis and the menstrual cycle,” Eye, vol. 18, no. 5, pp. 451–454, 2004. View at Publisher · View at Google Scholar · View at Scopus
  62. G. R. O'Connor, “Factors related to the initiation and recurrence of uveitis,” The American Journal of Ophthalmology, vol. 96, no. 5, pp. 577–599, 1983. View at Google Scholar · View at Scopus
  63. R. K. Agarwal, C.-C. Chan, B. Wiggert, and R. R. Caspi, “Pregnancy ameliorates induction and expression of experimental autoimmune uveitis,” Journal of Immunology, vol. 162, no. 5, pp. 2648–2654, 1999. View at Google Scholar · View at Scopus
  64. C.-C. Chan, G. F. Reed, Y. Kim, E. Agrón, and R. R. Buggage, “A correlation of pregnancy term, disease activity, serum female hormones, and cytokines in uveitis,” British Journal of Ophthalmology, vol. 88, no. 12, pp. 1506–1509, 2004. View at Publisher · View at Google Scholar · View at Scopus
  65. S. M. Monowarul Islam, J. Numaga, K. Matsuki, Y. Fujino, H. Maeda, and K. Masuda, “Influence of HLA-DRB1 gene variation on the clinical course of Vogt- Koyanagi-Harada disease,” Investigative Ophthalmology and Visual Science, vol. 35, no. 2, pp. 752–756, 1994. View at Google Scholar · View at Scopus
  66. S. M. M. Islam, J. Numaga, Y. Fujino et al., “HLA class II genes in Vogt-Koyanagi-Harada disease,” Investigative Ophthalmology and Visual Science, vol. 35, no. 11, pp. 3890–3896, 1994. View at Google Scholar · View at Scopus
  67. X. Y. Z. Xiao Yan Zhang, X.-M. Wang, and T.-S. Hu, “Profiling human leukocyte antigens in Vogt-Koyanagi-Harada syndrome,” The American Journal of Ophthalmology, vol. 113, no. 5, pp. 567–572, 1992. View at Google Scholar · View at Scopus
  68. J. Numaga, K. Matsuki, K. Tokunaga, T. Juji, and M. Mochizuki, “Analysis of human leukocyte antigen HLA-DRβ amino acid sequence in Vogt-Koyanagi-Harada syndrome,” Investigative Ophthalmology and Visual Science, vol. 32, no. 7, pp. 1958–1961, 1991. View at Google Scholar · View at Scopus
  69. A. Iqniebi, A. Gaafar, A. Sheereen et al., “HLA-DRB1 among patients with Vogt-Koyanagi-Harada disease in Saudi Arabia,” Molecular Vision, vol. 15, pp. 1876–1880, 2009. View at Google Scholar · View at Scopus
  70. A. C. Goldberg, J. H. Yamamoto, J. M. Chiarella et al., “HLA-DRB1*,0405 is the predominant allele in Brazilian patients with Vogt-Koyanagi-Harada disease,” Human Immunology, vol. 59, no. 3, pp. 183–188, 1998. View at Publisher · View at Google Scholar · View at Scopus
  71. X. Lin and X. Zhong, “A clinical analysis of 30 cases of sympathetic ophthalmia,” Yan ke xue bao, vol. 12, no. 4, pp. 191–192, 1996. View at Google Scholar · View at Scopus
  72. C. P. Castiblanco and R. A. Adelman, “Sympathetic ophthalmia,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 247, no. 3, pp. 289–302, 2009. View at Publisher · View at Google Scholar · View at Scopus
  73. A. Galor, J. L. Davis, H. W. Flynn Jr. et al., “Sympathetic ophthalmia: incidence of ocular complications and vision loss in the sympathizing eye,” The American Journal of Ophthalmology, vol. 148, no. 5, pp. 704.e2–710.e2, 2009. View at Publisher · View at Google Scholar · View at Scopus
  74. C.-C. Chan, F. G. Roberge, S. M. Whitcup, and R. B. Nussenblatt, “32 cases of sympathetic ophthalmia: a retrospective study at the National Eye Institute, Bethesda, Md, from 1982 to 1992,” Archives of Ophthalmology, vol. 113, no. 5, pp. 597–600, 1995. View at Google Scholar · View at Scopus
  75. S.-J. Sheu, H.-K. Kou, and J.-F. Chen, “Prognostic factors for Vogt-Koyanagi-Harada disease,” Journal of the Chinese Medical Association, vol. 66, no. 3, pp. 148–154, 2003. View at Google Scholar · View at Scopus
  76. S.-J. Sheu, H.-K. Kou, and J.-F. Chen, “Significant prognostic factors for Vogt-Koyanagi-Harada disease in the early stage,” Kaohsiung Journal of Medical Sciences, vol. 20, no. 3, pp. 97–105, 2004. View at Google Scholar · View at Scopus
  77. C. Kiyomoto, M. Imaizumi, K. Kimoto, H. Abe, S. Nakano, and K. Nakatsuka, “Vogt-Koyanagi-Harada disease in elderly Japanese patients,” International Ophthalmology, vol. 27, no. 2-3, pp. 149–153, 2007. View at Publisher · View at Google Scholar · View at Scopus
  78. T. Y. Y. Lai, R. P. S. Chan, C. K. M. Chan, and D. S. C. Lam, “Effects of the duration of initial oral corticosteroid treatment on the recurrence of inflammation in Vogt-Koyanagi-Harada disease,” Eye, vol. 23, no. 3, pp. 543–548, 2009. View at Publisher · View at Google Scholar · View at Scopus
  79. S.-P. Chee, A. Jap, and C. M. G. Cheung, “The prognostic value of angiography in Vogt-Koyanagi-Harada disease,” The American Journal of Ophthalmology, vol. 150, no. 6, pp. 888–893, 2010. View at Publisher · View at Google Scholar · View at Scopus
  80. M. M. Yang, T. Y. Lai, P. O. Tam et al., “Complement factor H and interleukin gene polymorphisms in patients with non-infectious intermediate and posterior uveitis,” Molecular Vision, vol. 18, pp. 1865–1872, 2012. View at Google Scholar
  81. S. Morita, Y. Nakamaru, N. Obara, M. Masuya, and S. Fukuda, “Characteristics and prognosis of hearing loss associated with Vogt-Koyanagi-Harada disease,” Audiology and Neurotology, vol. 19, no. 1, pp. 49–56, 2013. View at Google Scholar